HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Negotiations

PBM contracts, formulary dynamics, and the terms that matter

Aetna’s 2026 Step Therapy Expansion: Biologic Manufacturers Face $7B Battleground
Negotiations
By shifting step therapy policy on high-cost biologics, Aetna has upended specialty drug contracting -and set …
Mar 26, 2026
Patient Access and Insurer Costs: The Ongoing Battle Over Copay Accumulator Programs in 2025
Negotiations
Nearly $19B in annual copay assistance is up for grabs as insurers and drugmakers escalate their fight over ac…
Mar 3, 2026
How PBM Rebate Negotiations Actually Work: The Formulary Placement Auction That Sets Patient Costs
Negotiations
Behind closed doors, PBM rebate talks resemble a competitive auction, deciding which drugs make the formulary …
Jan 30, 2026
Express Scripts Quiet Formulary Shift: 47 Products Moved in Mid-Year Review
Negotiations
ESI moved 47 products across tiers in its mid-year formulary update, the largest mid-cycle adjustment in five …
Jul 18, 2025
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.